Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency
about
Deficiency of the sixth component of complement and susceptibility to Neisseria meningitidis infections: studies in 10 families and five isolated casesEpidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitisThe neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African childrenClinical implications of the specialised B cell response to polysaccharide encapsulated pathogensTherapeutic regulation of complement in patients with renal disease - where is the promise?Recurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian familyThe meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complementComplement factor I is upregulated in rat hepatocytes by interleukin-6 but not by interferon-gamma, interleukin-1beta, or tumor necrosis factor-alphaInfections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyEpidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.Pathogenesis and pathophysiology of bacterial meningitis.Infectious diseases associated with complement deficiencies.Rat complement factor I: molecular cloning, sequencing and expression in tissues and isolated cells.Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy.Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumabHajdu-Cheney syndrome.Recurrent infections, pericarditis and renal disease in a patient with total C2 deficiency and decreased NK cell function consistent with acute rheumatic fever and systemic lupus erythematosus.Reconstitution of the alternative pathway of complement by plasma infusions given to a patient with an SLE-like syndrome associated with a hereditary C3 dysfunctionSystemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE studyOuter membrane protein binding sites of complement component 3 during opsonization of Haemophilus influenzae.Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shockComplement factor P is a ligand for the natural killer cell-activating receptor NKp46.Characterization of Neisseria meningitidis strains causing disease in complement-deficient and complement-sufficient patients.C4 null phenotypes among lupus erythematosus patients are predominantly the result of deletions covering C4 and closely linked 21-hydroxylase A genes.Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in AfricansUpdate on meningococcal disease with emphasis on pathogenesis and clinical managementHigh prevalence of complement component C6 deficiency among African-Americans in the south-eastern USA.Detection of complement-mediated antibody-dependent bactericidal activity in a fluorescence-based serum bactericidal assay for group B Neisseria meningitidis.Waldenström's disease complicated by recurrent meningococcal arthritis.An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.Molecular epidemiological analysis of the changing nature of a meningococcal outbreak following a vaccination campaign.Role of complement in mouse macrophage binding of Haemophilus influenzae type b.Two distinct abnormalities in patients with C8 alpha-gamma deficiency. Low level of C8 beta chain and presence of dysfunctional C8 alpha-gamma subunit.Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. Difference between inhibition of immune precipitation and solubilization.Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement.Infectious complications in chronic lymphoid malignancy.The immunopathogenesis of meningococcal disease.Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycansComparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccineOuter membrane protein D15 is conserved among Haemophilus influenzae species and may represent a universal protective antigen against invasive disease.
P2860
Q24545566-0C72C062-D614-40FC-9A58-A73DDB1B4C3CQ24651311-5F3CFE8D-3587-46E2-900E-EDA0137353BDQ24651695-6D70EF40-7707-4B1D-8D31-998FE763E34DQ24671894-0B46EDDA-6D2A-49C3-B9A0-89EFA0C338C8Q26851705-37722C59-4BC1-41FC-B8E2-B49E7C57C377Q28291779-6B3559C7-F764-4595-9E6F-AA61A8A8E792Q28474974-04AE6F10-62CC-4FBC-BA6F-452B10E7C035Q28569082-516345FF-1C88-4926-93C8-36CC6261E24BQ28972389-0C59878F-BD9F-48FE-856A-13FC10111946Q30431534-9B6F152E-201F-44F5-A060-6A678271D0CFQ30450181-951509AC-E352-4850-8564-DAE4CB97D7D3Q30450183-492A0C7C-FA7C-4B14-A9B5-948A7CC8781EQ30821832-A5CE8971-F097-4002-BEAA-5AE3AEB8D081Q33397450-A5F7A061-E770-4C08-9A96-10759E00956BQ33438559-871D6FC1-DE78-4C8C-A7EE-F446FCEDF2D7Q33566297-636D8929-5BEE-4C3E-91D4-D9D4BC46A6DAQ33566301-70CC46DD-061D-4550-9D77-447353E9B3E8Q33566734-2B92B308-DDED-46C6-8490-4D1C5D3510EFQ33586908-D1355A2B-7A62-4F73-81FA-E98FDCCD075DQ33616949-0D84C88A-6AEF-4261-ACDE-66182A4171C5Q33620607-3E2B2A15-59F5-4B22-B940-73D750EA646FQ33642649-36C3E34E-E4FF-4A2B-A3A9-2CFC10422535Q33676641-076EED17-EE25-4C9C-BBC5-5BCCC63924C7Q33676915-8CC95F00-DE99-4C40-B19A-54DA2A1FDFEEQ33733849-800DBC78-25AB-42EC-9123-34D8B15BEA2CQ33812435-DFA4079E-8273-44AB-BF62-D396D46FE83FQ33815750-01FDEC29-634F-45F1-B3FB-68FE6537D198Q33968762-3F696F59-D989-40FC-B29A-94AE7FC1727BQ33973254-8021A61D-9AB7-4902-8816-9D788429C9C1Q34105747-E660F139-3CE3-4830-9A7F-107ABF55CB9EQ34201588-ABE9EE4F-1008-450E-86F9-D1DD25937284Q34240605-F0746E20-7910-4D44-BDD2-689D44F6E004Q34260629-429E38CD-AA30-498A-917F-B7E1E5C91E6CQ34568311-74BE85EB-2B7F-44D4-92F5-3F24DBFBC5F5Q34570640-44FDDB42-E85A-4BC3-B89F-084DAFA86CC4Q34678282-B6452C34-65D6-426D-AA81-3E3AE9F173DEQ35144175-FC0E3E4B-043D-46B9-847C-7D21A49CF3A3Q35187024-26B3590F-680E-4B2B-B216-817E46EA9BA1Q35437531-4B2454E2-C380-4DBF-A6F7-89A4D59EE57AQ35554942-CA2215F9-017E-4828-8ADA-17B637FA9A9B
P2860
Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency
description
1984 nî lūn-bûn
@nan
1984 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Complement deficiency states a ...... ctions in an immune deficiency
@ast
Complement deficiency states a ...... ctions in an immune deficiency
@en
Complement deficiency states a ...... ctions in an immune deficiency
@nl
type
label
Complement deficiency states a ...... ctions in an immune deficiency
@ast
Complement deficiency states a ...... ctions in an immune deficiency
@en
Complement deficiency states a ...... ctions in an immune deficiency
@nl
prefLabel
Complement deficiency states a ...... ctions in an immune deficiency
@ast
Complement deficiency states a ...... ctions in an immune deficiency
@en
Complement deficiency states a ...... ctions in an immune deficiency
@nl
P3181
P1433
P1476
Complement deficiency states a ...... ctions in an immune deficiency
@en
P2093
P304
P3181
P356
10.1097/00005792-198409000-00001
P407
P577
1984-09-01T00:00:00Z